GO:0006520 | cellular amino acid metabolic process | 33.33% (19/57) | 5.0 | 0.0 | 0.0 |
GO:0019752 | carboxylic acid metabolic process | 35.09% (20/57) | 4.64 | 0.0 | 0.0 |
GO:0006082 | organic acid metabolic process | 35.09% (20/57) | 4.64 | 0.0 | 0.0 |
GO:0043436 | oxoacid metabolic process | 35.09% (20/57) | 4.64 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 38.6% (22/57) | 4.0 | 0.0 | 0.0 |
GO:0016053 | organic acid biosynthetic process | 17.54% (10/57) | 5.62 | 0.0 | 0.0 |
GO:0046394 | carboxylic acid biosynthetic process | 17.54% (10/57) | 5.62 | 0.0 | 0.0 |
GO:0008652 | cellular amino acid biosynthetic process | 15.79% (9/57) | 5.82 | 0.0 | 0.0 |
GO:0009072 | aromatic amino acid family metabolic process | 12.28% (7/57) | 6.17 | 0.0 | 0.0 |
GO:0044283 | small molecule biosynthetic process | 17.54% (10/57) | 4.79 | 0.0 | 0.0 |
GO:0016874 | ligase activity | 19.3% (11/57) | 4.37 | 0.0 | 0.0 |
GO:1901607 | alpha-amino acid biosynthetic process | 12.28% (7/57) | 5.82 | 0.0 | 0.0 |
GO:1901605 | alpha-amino acid metabolic process | 14.04% (8/57) | 5.18 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 38.6% (22/57) | 2.38 | 0.0 | 0.0 |
GO:0009073 | aromatic amino acid family biosynthetic process | 10.53% (6/57) | 6.24 | 0.0 | 0.0 |
GO:0006418 | tRNA aminoacylation for protein translation | 14.04% (8/57) | 4.96 | 0.0 | 0.0 |
GO:0043039 | tRNA aminoacylation | 14.04% (8/57) | 4.78 | 0.0 | 0.0 |
GO:0043038 | amino acid activation | 14.04% (8/57) | 4.78 | 0.0 | 0.0 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 14.04% (8/57) | 4.78 | 0.0 | 0.0 |
GO:0004812 | aminoacyl-tRNA ligase activity | 14.04% (8/57) | 4.78 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 31.58% (18/57) | 2.56 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 31.58% (18/57) | 2.52 | 0.0 | 0.0 |
GO:0140101 | catalytic activity, acting on a tRNA | 14.04% (8/57) | 4.3 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 52.63% (30/57) | 1.51 | 0.0 | 0.0 |
GO:0003824 | catalytic activity | 54.39% (31/57) | 1.44 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 21.05% (12/57) | 3.07 | 0.0 | 0.0 |
GO:0052803 | imidazole-containing compound metabolic process | 7.02% (4/57) | 6.5 | 0.0 | 0.0 |
GO:0006547 | histidine metabolic process | 7.02% (4/57) | 6.5 | 0.0 | 0.0 |
GO:0000105 | histidine biosynthetic process | 7.02% (4/57) | 6.5 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 28.07% (16/57) | 2.39 | 0.0 | 0.0 |
GO:0006399 | tRNA metabolic process | 14.04% (8/57) | 3.94 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 38.6% (22/57) | 1.77 | 0.0 | 1e-06 |
GO:0034641 | cellular nitrogen compound metabolic process | 29.82% (17/57) | 2.09 | 0.0 | 1e-06 |
GO:0034660 | ncRNA metabolic process | 14.04% (8/57) | 3.57 | 0.0 | 2e-06 |
GO:0009058 | biosynthetic process | 26.32% (15/57) | 2.25 | 0.0 | 2e-06 |
GO:0036094 | small molecule binding | 31.58% (18/57) | 1.94 | 0.0 | 2e-06 |
GO:0016829 | lyase activity | 10.53% (6/57) | 4.36 | 0.0 | 2e-06 |
GO:0044237 | cellular metabolic process | 38.6% (22/57) | 1.65 | 0.0 | 2e-06 |
GO:0016835 | carbon-oxygen lyase activity | 7.02% (4/57) | 5.5 | 1e-06 | 6e-06 |
GO:0140098 | catalytic activity, acting on RNA | 14.04% (8/57) | 3.3 | 1e-06 | 7e-06 |
GO:0019438 | aromatic compound biosynthetic process | 15.79% (9/57) | 2.93 | 2e-06 | 1.2e-05 |
GO:0071704 | organic substance metabolic process | 38.6% (22/57) | 1.47 | 3e-06 | 1.7e-05 |
GO:1901362 | organic cyclic compound biosynthetic process | 15.79% (9/57) | 2.84 | 3e-06 | 1.8e-05 |
GO:0044238 | primary metabolic process | 36.84% (21/57) | 1.51 | 4e-06 | 2e-05 |
GO:0043168 | anion binding | 28.07% (16/57) | 1.81 | 6e-06 | 2.9e-05 |
GO:0044249 | cellular biosynthetic process | 21.05% (12/57) | 2.14 | 1.2e-05 | 5.9e-05 |
GO:0008144 | drug binding | 22.81% (13/57) | 2.0 | 1.3e-05 | 6.4e-05 |
GO:1901576 | organic substance biosynthetic process | 21.05% (12/57) | 2.08 | 1.8e-05 | 8.4e-05 |
GO:0043167 | ion binding | 31.58% (18/57) | 1.45 | 4.4e-05 | 0.000203 |
GO:0016836 | hydro-lyase activity | 5.26% (3/57) | 5.24 | 5.3e-05 | 0.000242 |
GO:0000166 | nucleotide binding | 24.56% (14/57) | 1.68 | 7.3e-05 | 0.000318 |
GO:1901265 | nucleoside phosphate binding | 24.56% (14/57) | 1.68 | 7.3e-05 | 0.000318 |
GO:0008150 | biological_process | 54.39% (31/57) | 0.87 | 8.3e-05 | 0.000359 |
GO:0005524 | ATP binding | 19.3% (11/57) | 1.88 | 0.00015 | 0.000634 |
GO:0018130 | heterocycle biosynthetic process | 12.28% (7/57) | 2.56 | 0.000159 | 0.000648 |
GO:0032559 | adenyl ribonucleotide binding | 19.3% (11/57) | 1.87 | 0.000158 | 0.000656 |
GO:0030554 | adenyl nucleotide binding | 19.3% (11/57) | 1.86 | 0.000167 | 0.000667 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 5.26% (3/57) | 4.6 | 0.000223 | 0.000875 |
GO:0050662 | coenzyme binding | 10.53% (6/57) | 2.72 | 0.000269 | 0.001041 |
GO:0006139 | nucleobase-containing compound metabolic process | 17.54% (10/57) | 1.83 | 0.000413 | 0.001568 |
GO:0003674 | molecular_function | 63.16% (36/57) | 0.64 | 0.000479 | 0.001789 |
GO:0016070 | RNA metabolic process | 14.04% (8/57) | 2.09 | 0.000493 | 0.001814 |
GO:0009987 | cellular process | 40.35% (23/57) | 0.93 | 0.000773 | 0.002796 |
GO:0035639 | purine ribonucleoside triphosphate binding | 19.3% (11/57) | 1.58 | 0.00089 | 0.003172 |
GO:0032555 | purine ribonucleotide binding | 19.3% (11/57) | 1.57 | 0.000926 | 0.00325 |
GO:1901363 | heterocyclic compound binding | 29.82% (17/57) | 1.14 | 0.000981 | 0.003337 |
GO:0097159 | organic cyclic compound binding | 29.82% (17/57) | 1.14 | 0.000981 | 0.003337 |
GO:0017076 | purine nucleotide binding | 19.3% (11/57) | 1.56 | 0.001002 | 0.00336 |
GO:0032553 | ribonucleotide binding | 19.3% (11/57) | 1.53 | 0.001192 | 0.003937 |
GO:0097367 | carbohydrate derivative binding | 19.3% (11/57) | 1.52 | 0.001237 | 0.00403 |
GO:0048037 | cofactor binding | 10.53% (6/57) | 2.22 | 0.001705 | 0.005475 |
GO:0090304 | nucleic acid metabolic process | 14.04% (8/57) | 1.73 | 0.002532 | 0.008019 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.26% (3/57) | 3.36 | 0.002961 | 0.009249 |
GO:0019842 | vitamin binding | 5.26% (3/57) | 3.32 | 0.003227 | 0.009944 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 5.26% (3/57) | 3.28 | 0.003508 | 0.010665 |
GO:0003879 | ATP phosphoribosyltransferase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004834 | tryptophan synthase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004150 | dihydroneopterin aldolase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0046040 | IMP metabolic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0003848 | 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004358 | glutamate N-acetyltransferase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0006525 | arginine metabolic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0006526 | arginine biosynthetic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004399 | histidinol dehydrogenase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004107 | chorismate synthase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004814 | arginine-tRNA ligase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0006188 | IMP biosynthetic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004425 | indole-3-glycerol-phosphate synthase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0016838 | carbon-oxygen lyase activity, acting on phosphates | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:1902223 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid biosynthetic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0009113 | purine nucleobase biosynthetic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0009112 | nucleobase metabolic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0006144 | purine nucleobase metabolic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004637 | phosphoribosylamine-glycine ligase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0003855 | 3-dehydroquinate dehydratase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004635 | phosphoribosyl-AMP cyclohydrolase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004764 | shikimate 3-dehydrogenase (NADP+) activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:1902221 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0009094 | L-phenylalanine biosynthetic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0006558 | L-phenylalanine metabolic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0046112 | nucleobase biosynthetic process | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0004664 | prephenate dehydratase activity | 1.75% (1/57) | 6.82 | 0.00884 | 0.019014 |
GO:0016491 | oxidoreductase activity | 12.28% (7/57) | 1.56 | 0.009016 | 0.019211 |
GO:0016830 | carbon-carbon lyase activity | 3.51% (2/57) | 4.01 | 0.006527 | 0.01958 |
GO:0055114 | oxidation-reduction process | 12.28% (7/57) | 1.63 | 0.006794 | 0.020116 |
GO:0000287 | magnesium ion binding | 3.51% (2/57) | 3.65 | 0.010728 | 0.022648 |
GO:0072522 | purine-containing compound biosynthetic process | 3.51% (2/57) | 3.57 | 0.011922 | 0.024939 |
GO:0016832 | aldehyde-lyase activity | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0016743 | carboxyl- or carbamoyltransferase activity | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0016597 | amino acid binding | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009095 | aromatic amino acid family biosynthetic process, prephenate pathway | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0006760 | folic acid-containing compound metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009396 | folic acid-containing compound biosynthetic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0019238 | cyclohydrolase activity | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0004329 | formate-tetrahydrofolate ligase activity | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0006528 | asparagine metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0006568 | tryptophan metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0006586 | indolalkylamine metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0042430 | indole-containing compound metabolic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0006529 | asparagine biosynthetic process | 1.75% (1/57) | 5.82 | 0.017603 | 0.030177 |
GO:0072521 | purine-containing compound metabolic process | 3.51% (2/57) | 3.18 | 0.020221 | 0.034406 |
GO:0005488 | binding | 35.09% (20/57) | 0.67 | 0.016768 | 0.034441 |
GO:0016740 | transferase activity | 14.04% (8/57) | 1.27 | 0.016659 | 0.034529 |
GO:0051287 | NAD binding | 3.51% (2/57) | 3.07 | 0.023394 | 0.03951 |
GO:0042559 | pteridine-containing compound biosynthetic process | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0004486 | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0006576 | cellular biogenic amine metabolic process | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0046148 | pigment biosynthetic process | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0042558 | pteridine-containing compound metabolic process | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0044106 | cellular amine metabolic process | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0031406 | carboxylic acid binding | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0043177 | organic acid binding | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0009067 | aspartate family amino acid biosynthetic process | 1.75% (1/57) | 5.24 | 0.02629 | 0.039961 |
GO:0030170 | pyridoxal phosphate binding | 3.51% (2/57) | 3.01 | 0.025052 | 0.041693 |
GO:0070279 | vitamin B6 binding | 3.51% (2/57) | 3.01 | 0.025052 | 0.041693 |
GO:0005737 | cytoplasm | 3.51% (2/57) | 2.91 | 0.028508 | 0.043046 |